Ulland Investment Advisors, LLC Laboratory Corp Of America Holdings Transaction History

Ulland Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$209.01 - $232.56 $19,019 - $21,162	-91 Reduced 4.84%	1,790 $391,000
Q4 2023 Jan 16, 2024	SELL	$197.69 - $227.29 $4,942 - $5,682	-25 Reduced 1.31%	1,881 $428,000
Q3 2023 Oct 23, 2023	SELL	$201.05 - $221.7 $43,627 - $48,108	-217 Reduced 10.22%	1,906 $383,000
Q1 2023 Apr 17, 2023	SELL	$213.32 - $257.83 $308,674 - $373,080	-1,447 Reduced 40.53%	2,123 $487,000
Q4 2022 Jan 31, 2023	SELL	$203.72 - $248.97 $132,418 - $161,830	-650 Reduced 15.4%	3,570 $841,000
Q3 2022 Oct 12, 2022	BUY	$204.81 - $262.19 $8,192 - $10,487	40 Added 0.96%	4,220 $864,000
Q2 2022 Jul 25, 2022	SELL	$213.86 - $277.87 $349,661 - $454,317	-1,635 Reduced 28.12%	4,180 $980,000
Q1 2022 May 09, 2022	BUY	$259.82 - $298.18 $71,450 - $81,999	275 Added 4.96%	5,815 $1.53 Million
Q4 2021 Feb 16, 2022	BUY	$271.6 - $314.21 $1.5 Million - $1.74 Million	5,540 New	5,540 $1.74 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Ulland Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ulland Investment Advisors, LLC with notifications on news.